Introduction {#Sec1}
============

Clavicle fractures in adults occur quite frequently; approximately 5% of all fractures concern the clavicle. The vast majority of fractures, approximately 80%, is located in the midshaft of the clavicle and half of these fractures are displaced \[[@CR25], [@CR27]\].

In the past, treatment of choice for most midshaft clavicle fractures was nonoperative with a sling or figure-of-eight bandage \[[@CR24], [@CR30]\]. Reported nonunion rates following surgical fixation of clavicle fractures were initially higher than those reported following nonoperative treatment \[[@CR24], [@CR30]\]. More recent studies, however, suggest higher complication and nonunion rates of up to 15% following nonoperative treatment, in particular for patients with displaced midshaft clavicle fractures (DMCF) \[[@CR6], [@CR12], [@CR17], [@CR22], [@CR34], [@CR39]\]. In addition, these patients are at high risk of residual pain, disappointing cosmesis and shoulder dysfunction \[[@CR6], [@CR12], [@CR22], [@CR39]\].

A regularly used surgical treatment option for DMCF is plate fixation. An advantage of plate fixation is the immediate stability it provides which enables early postoperative mobilization \[[@CR13], [@CR23], [@CR24]\]. Several types of plates and fixation methods have been previously described; these include (precontoured) dynamic compression plates (DCP), tubular plates or reconstruction plates \[[@CR13], [@CR23]\]. Although high success rates of plate fixation of displaced clavicle fractures have been shown, reported complications of plate fixation include implant failure, (deep) infections, implant prominence, poor cosmesis, nonunions and refracture as a result of removal of the plate \[[@CR4], [@CR8], [@CR9]\].The study quality and scientific levels of evidence at which complications are presented, however, vary greatly in literature. Different reviews are performed on clavicle fractures, but none of these reviews specifically address the complications of plate fixation for dislocated midshaft clavicular fractures.

This systematic review aims at answering the following questions: (1) What is the incidence of minor and major complications after surgical plate fixation of acute DMCF? (2) What is the value of reported complications in terms of the scientific level of evidence at which they are presented? (3) What are the frequency and severity of the long-term consequences of major complications after plate fixation? (4) what conclusions may be drawn from these findings and how may it influence treatment of midshaft clavicle fractures?

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

On 4th April 2011, a computer-aided search using EMBASE and PUBMED/MEDLINE was conducted using the first two phases of the optimal search strategy from the Cochrane Handbook (<http://www.cochrane-handbook.com>). This strategy was combined with a subject specific search ("[Appendix I](#Sec12){ref-type="sec"}"). Reference and citation tracking was used to complete the search database.

Inclusion criteria {#Sec4}
------------------

Studies included for review reported complications after acute, displaced, midshaft clavicle fractures treated with plate fixation alone or in comparison to either treatment with intramedullary pin fixation and/or nonoperative treatment. Degree of fracture displacement had to be noted in the "[Materials and methods](#Sec2){ref-type="sec"}" section for studies to be enrolled for further analysis. Studies in English, Dutch, German or French were assessed for inclusion. Case reports, biomechanical studies, papers describing a surgical technique and reviews were excluded from the database. Studies reporting on complications of the operative treatment of clavicle malunions, nonunions, open fractures, multiple fractures to the shoulder girdle, pathologic fractures, additional morbidity (i.e. floating shoulder) or fractures that had initial nonoperative treatment as starting point were also excluded.

Selection of studies {#Sec5}
--------------------

After the initial search strategy was performed, the remaining studies were screened for inclusion criteria based on their title/abstract by two researchers (FJGW, OAJvdM). Studies eligible for inclusion were additionally read completely for final inclusion. Finally, (prospective) trials without any notice of ethics committee consultation or approval were excluded from further assessment. Disagreement between the reviewers was resolved by discussion with another independent reviewer (RMH).

Quality assessment {#Sec6}
------------------

Two quality assessment tools were used to assess the methodological quality of the final selection of studies. Assessment was performed without masking the source or authorship of trial reports. The two tools used were the level of evidence (LoE) rating according to the Oxford Centre of Evidence Based Medicine (<http://www.cebm.net>) and the modified version of the Cochrane Bone, Joint and Muscle Trauma Group's former quality assessment tool (QAT, <http://www.cochrane-handbook.com>). Studies were first labeled according to their LoE (Level I: high evidence, Level II: moderate evidence, Level III: low evidence, Level IV: very low evidence). Secondly, the QAT was used to assess the research quality into more detail. The QAT is a tool that scores an article on 11 items: 7 items on internal validity and 4 items on external validity. Disagreement between the reviewers about the quality assessment was again resolved by discussion with another independent reviewer (RM).

Data extraction and analysis {#Sec7}
----------------------------

Included studies were ranked according to their levels of evidence. The study characteristics, including design, type and position of plate used for fixation and follow-up time were also taken into account.

Complications following the plate fixation of DMCF were identified and broken down into the following categories, if possible; bone-healing problems (nonunion and symptomatic malunion), infection (deep or wound), implant related problems (breakage, mechanical failure, irritation, angulation), plate debridement, removal or revision, neurovascular problems (transient or persistent brachial plexus symptoms, regional pain syndrome), refracture after plate removal and other complications. These categories were further subcategorized into two groups; major and minor complications. Major complications are characterized as a complication that needs another surgery to either remove or revise the plate as a result of the complication presented. Major complications are: nonunions, symptomatic malunion, deep infections, mechanical failure, irritation, breakage of the implant, angulation and refracture after plate removal. Minor complications are characterized as a complication that does not need another surgery and where a small intervention (i.e. oral antibiotics) may suffice. Minor complications are: wound infection and neurovascular problems. To avoid misinterpretation, the definitions of various complications stated in the reviewed studies were used in our analysis as much as possible.

Results {#Sec8}
=======

A total of 196 articles were identified, of which 27 were potentially relevant after screening the title and abstract and excluding doubles (Fig. [1](#Fig1){ref-type="fig"}). Full text screening resulted in 11 studies eligible for final quality assessment. There was no disagreement between the reviewers about the selection of the 11 final articles.Fig. 1Flowchart demonstrating the article search and appraisal process. Search was conducted on April 6th 2011. *Asterisk* excluded were one case report \[[@CR29]\] and two studies in which there was no clear distinction made between postoperative complications after acute fractures and nonunions \[[@CR9], [@CR14]\]. Seven studies included complicated fractures and made no distinction with uncomplicated fractures when describing complications \[[@CR3], [@CR8], [@CR15], [@CR18]--[@CR20], [@CR32]\]. One study was a surgical technique paper \[[@CR2]\], one study only reported outcomes and no complications \[[@CR28]\], two studies had no clear definition of indication for surgery \[[@CR1], [@CR38]\] and, finally, two studies included different kinds of clavicle fractures (pathological, distal and nonunions) \[[@CR11], [@CR26]\]

Level of evidence {#Sec9}
-----------------

Three studies were designed as randomized controlled trials and marked with the highest LoE (Table [1](#Tab1){ref-type="table"}) \[[@CR5], [@CR10], [@CR33]\]. All three studies report considerable wound infection rates (5--22%) \[[@CR5], [@CR10], [@CR33]\]. In addition, Shen et al. \[[@CR33]\] report high nonunion rates of 13% in comparison to Ferran et al. \[[@CR10]\] and the COTS \[[@CR5]\], 0 and 3%, respectively. They \[[@CR5], [@CR10]\], on the other hand, report significant rates of implant-related problems requiring plate debridement, removal or even revision fixation, 10 and 53%.Table 1Studies graded level of evidence I according to the Oxford Centre of Evidence Based Medicine (<http://www.cebm.net>)COTS \[[@CR5]\]Ferran et al. \[[@CR10]\]Shen et al. \[[@CR33]\]*Study characteristics*DesignRCT; plating versus nonoperative treatmentRCT; plating versus pin fixationRCT; 'normal' plating versus 3D-aided platingNumber of plate fixations*N* = 62*N* = 15*N* = 133Type of plate (times used)LCDCP (44), reconstruction plate (15), precontoured plate(4), Other (4)LCDCP (15)Reconstruction plate; 'Normal' plating (66), 3D-aided plating 67)Plate positioningSuperiorSuperiorSuperiorMean time to follow-up in months (range)1212 (5--28)12*Complication rate*Bone-healing problem Nonunion2 (3%)0 (0%)8 (12%) versus 1 (1%) (Symptomatic) Malunion0n/a Infection Wound3 (5%)3 (20%)12 (19%) versus 2 (3%) Deepn/an/an/aImplant breakage/failure/irritation Irritation6 (10%)3 (20%)n/a Mechanical failuren/an/an/aPlate debridement/removal/revision6 (10%)8^a^ (53%)n/aNeurovascular problems Brachial plexus symptoms8 (13%)1 (7%)n/a Regional pain syndrome01 (7%)n/aRefracture after plate removal0n/an/aOther4 (6%)n/a0*RCT* randomized controlled trial, *LCDCP* limited contact dynamic compression plate, *3D* 3-dimensional, *n/a* not applicable (complication not mentioned in study)^a^One plate was removed because the patient was a high level athlete

One study was graded LoE II, being designed as prospective cohort study \[[@CR16]\] and reported complications were mainly implant related (Table [2](#Tab2){ref-type="table"}). A total of four studies were designed as retrospective cohort studies and therefore labeled as LoE III \[[@CR7], [@CR21], [@CR35], [@CR36]\]. Again the main complications reported in these four studies were implant-related problems (Table [3](#Tab3){ref-type="table"}). Finally, three studies were assigned to LoE IV, all of them being retrospective case series \[[@CR4], [@CR31], [@CR37]\]. The majority of complications again concerned the used implants (Table [4](#Tab4){ref-type="table"}).Table 2Studies graded level of evidence I according to the Oxford Centre of Evidence Based Medicine (<http://www.cebm.net>)Kuhlshrestha et al. \[[@CR16]\]*Study characteristics*DesignProspective cohort; plating versus nonoperative treatmentNumber of plate fixations*N* = 45Type of plate (times used)Reconstruction plate (45)Plate positioningSuperior (15), anterior inferior (30)Mean time to follow-up in months (range)12*Complication rate*Bone-healing problem Nonunion0 (Symptomatic) Malunion2 (4%)Infection Woundn/a Deepn/aImplant breakage/failure/irritation Irritation4 (9%) Mechanical failuren/aPlate debridement/removal/revision4 (9%)Neurovascular problems Brachial plexus symptomsn/a Regional pain syndromen/aRefracture after plate removal0Other4 (9%)*n/a* not applicable (complication not mentioned in study)Table 3Studies graded level of evidence III according to the Oxford Centre of Evidence Based Medicine (<http://www.cebm.net>)Vanbeek et al. \[[@CR36]\]Cho et al. \[[@CR7]\]Liu et al. \[[@CR21]\]*Study characteristics*DesignRetrospective cohort study; noncontoured plating versus contoured platingRetrospective cohort study; reconstruction plating versus reconstruction locking platingRetrospective cohort study; plating versus pin fixationNumber of plate fixations*N* = 42*N* = 41*N* = 59Type of plate (times used)Noncontoured (14); DCP (4), LCP (2), LCDCP (4), reconstruction plate (4), precontoured (28); locking clavicle plate (28)Precontoured; reconstruction plate (19), reconstruction LCP (22)Reconstruction LCP (59)Plate positioningSuperiorSuperiorSuperiorMean time to follow-up in months (range)1213 (7--35) versus 12 (7--24)12*Complication rate*Bone-healing problem Nonunion0 versus 1 (4%)06 (10%) (Symptomatic) Malunionn/a02 (3%)Infection Wound0 versus 1 (4%)06 (10%) Deepn/a0 Implant breakage/failure/irritation Irritation9 (64%)^a^ versus 9 (32%)012 (20%) Mechanical failuren/a04 (8%)Plate debridement/removal/revision3 (21%) versus 3 (11%)n/a14 (24%)Neurovascular problems Brachial plexus symptomsn/an/an/a Regional pain syndromen/a2 (11%) versus 1 (5%)n/aRefracture after plate removal0 versus 1 (4%)0n/aOther0 versus 2 (7%)7 (39%) versus 5 (23%)n/a Thyagarajan et al. \[[@CR35]\]*Study characteristics*DesignRetrospective cohort study; plating versus pin fixation versus nonoperative treatmentNumber of plate fixations*N* = 16Type of plate (times used)LCDCP (16)Plate positioningSuperiorMean time to follow-up in months (range)6 (4--11)*Complication rate*Bone-healing problem Nonunion1 (6%) (Symptomatic) Malunionn/aInfection Wound1 (6%) Deep1 (6%)Implant breakage/failure/irritation Irritation2 (13%) Mechanical failuren/aPlate debridement/removal/revision2 (13%)Neurovascular problems Brachial plexus symptoms4 (25%) Regional pain syndrome6 (38%) Refracture after plate removaln/a Other1 (6%)*LCDCP* limited contact dynamic compression plate, *n/a* not applicable (complication not mentioned in study)^a^Removed noncontoured plates included DCP (1), LCDCP (1) and reconstruction plate (1)Table 4Studies graded level of evidence IV according to the Oxford Centre of Evidence Based Medicine (<http://www.cebm.net>) Russo et al. \[[@CR31]\]Verborgt et al. \[[@CR37]\]Böstman et al. \[[@CR4]\]*Study characteristics*DesignRetrospective case seriesRetrospective case seriesRetrospective case seriesNumber of plate fixations*N* = 43*N* = 39*N* = 103Type of plate (times used)Mennen-platePrecontoured; reconstruction plate (?) LCDCP (?)DCP (57), reconstruction plate (46)Plate positioningSuperiorAnteriorAnterior (57)\
Superior (46)Mean time to follow-up in months (range)12323 (6--53)*Complication rate*Bone-healing problem Nonunion2 (5%)2 (5%)3 (3%) (Symptomatic) Malunionn/an/a12 (12%)Infection Wound04 (10%)3 (3%) Deep03 (8%)5 (5%)Implant breakage/failure/irritation Irritation0n/an/a Mechanical failure02 (5%)16 (16%)Plate debridement/removal/revision13^a^ (30%)7 (18%)14 (14%) + 54 (52%)^b^Neurovascular problems Brachial plexus symptoms10 (23%)3 (8%)2 (2%) Regional pain syndromen/an/an/aRefracture after plate removaln/a2 (5%)^c^1 (1%)Other2 (5%)n/an/a*LCDCP* low contact dynamic compression plate, *DCP* dynamic compression plate, *n/a* not applicable (complication not mentioned in study)^a^11 patients requested removal of the plate for cosmetic reasons^b^54 patients underwent routine plate removal^c^Refractures both after LCDCP plates

A total of 10 of the 11 assessed studies reported the usage of superior position for plate fixation \[4, 5, 7, 10, 16, 21, 31 33, 35, 36\]. Anterior or anterior inferior plate positioning was analyzed in three studies \[[@CR4], [@CR16], [@CR37]\]. The reconstruction plate and the low-contact dynamic compression plate (LCDCP) were the two most commonly used types for plate fixation.

Quality assessment {#Sec10}
------------------

The majority of studies had well-defined in- and exclusion criteria, interventions and outcome measures. Adequate duration of follow-up was considered a minimum of 1 year which applied to most studies (Table [5](#Tab5){ref-type="table"}). The study by the Canadian Orthopedic Trauma Society \[[@CR5]\] was graded the strongest of selected studies and of highest scientific quality.Table 5Quality assessment outcome of all analyzed studies according to the modified version of the Cochrane Bone, Joint and Muscle Trauma Group's former quality assessment tool (QAT, <http://www.cochrane-handbook.com>)StudyAllocation concealmentIntention- to-treat analysisAssessor blindingComparable baseline characteristicsParticipant blindingTreatment provider blindingCare program comparabilityDefined in - and exclusion criteriaCOTS et al. \[[@CR29]\]22020022Kulshrestva et al. \[[@CR32]\]22020022Ferran et al. \[[@CR30]\]22020022Shen et al. \[[@CR31]\]22222001Liu et al. \[[@CR35]\]00020022Cho et al. \[[@CR34]\]00010021Vanbeek et al. \[[@CR33]\]00020022Russo et al. \[[@CR37]\]00000001Bostman et al. \[[@CR4]\]00000002Thyagarajan et al. \[[@CR36]\]00020002Verborgt et al. \[[@CR38]\]00000001StudyWell-defined interventionsWell-defined outcome measuresClinically useful diagnostic testsAdequate duration of follow-upQAT ScoreCOTS et al. \[[@CR29]\]2222**18**Kulshrestva et al. \[[@CR32]\]2212**17**Ferran et al. \[[@CR30]\]2212**17**Shen et al. \[[@CR31]\]2002**15**Liu et al. \[[@CR35]\]2222**14**Cho et al. \[[@CR34]\]2221**11**Vanbeek et al. \[[@CR33]\]1220**11**Russo et al. \[[@CR37]\]2222**9**Bostman et al. \[[@CR4]\]2211**8**Thyagarajan et al. \[[@CR36]\]1200**7**Verborgt et al. \[[@CR38]\]1212**7**Bold values indicate that the higher the value, the better methodological quality and least chance of bias, with a maximum score of 24*QAT* quality assessment tool

Discussion {#Sec11}
==========

The goal of this systematic review was to document the (prevalence of) complications after plate fixation of DMCF. To obtain the best available evidence, relevant studies were scored on scientific methodology and the LoE they provide. We attempted to find an answer to the following questions; what is the incidence of minor and major complications after surgical plate fixation of acute DMCF? What is the value of reported complications in terms of the scientific level of evidence at which they are presented? What are the frequency and severity of the long-term consequences of major complications after plate fixation? And what conclusions may be drawn from these findings and how may it influence treatment of midshaft clavicle fractures? In response to our second question, we found that only three of the eligible studies provided the highest LoE \[[@CR5], [@CR10], [@CR33]\]. Two of these studies included a sample-size calculation \[[@CR5], [@CR10]\]. One study was a prospective cohort study but scored very well on quality assessment \[[@CR16]\]. Based on their quality of methodology, we believe the studies by the COTS \[[@CR5]\] and Kulshrestha et al. \[[@CR16]\] to provide the best available evidence.

In search of an answer to our first question, we found nonunion rates were no higher than 10% in all analysed studies but one \[[@CR4], [@CR5], [@CR7], [@CR10], [@CR16], [@CR21], [@CR31], [@CR33], [@CR35], [@CR36]\]. If reported on infection rates, both wound and deep infections were also below 10% in all but two studies \[[@CR4], [@CR5], [@CR7], [@CR10], [@CR21], [@CR31], [@CR33], [@CR35], [@CR36]\]. The vast majority of these infections were wound infections, reportedly treated successfully with oral antibiotics. Neurovascular complications included brachial plexus symptoms and regional pain syndromes and ranged in prevalence from 0 to 38%, all reportedly were transient \[[@CR4], [@CR5], [@CR7], [@CR10], [@CR31], [@CR35], [@CR37]\]. Based on these figures, the incidence of minor complications (wound infections and neurovascular problems) is low.

Regardless of the LoE provided, the vast majority of complications seem to be implant related, with irritation or failure of the plate being consistently reported on in almost every study, on average ranging from 9 to 64% \[[@CR5], [@CR10], [@CR16], [@CR21], [@CR33], [@CR36]\].This is a point of concern, considering that, even in the better designed studies, a second operation with plate debridement, removal or revision was required at best in one out of every ten patients treated, in some studies even up to one out of every two patients \[[@CR4], [@CR5], [@CR10], [@CR16], [@CR21], [@CR31], [@CR35], [@CR36]\]. There is a relatively small risk of refracture after plate removal, between 1 and 5% \[[@CR4], [@CR31], [@CR36]\]. However, it must be noted that only three of the 11 analyzed studies report on these numbers. In one study, two refractures after plate removal were reported \[[@CR31]\]. This study compared LCDCP plates and reconstruction plates, and both refractures occurred after removal of LCDCP plates. Another study had a refracture after removal of a precountoured plate; the Locking Clavicle Plate \[[@CR33]\]. The last refracture was reported after removal of an eight-screw dynamic compression plate \[[@CR4]\]. The numbers presented above provide us with an answer to our third question. We conclude, based on the figures of plate debridement, removal or revision, that the incidence of major complications is high, ranging up to 64%. Major complications require another surgery, but this surgery does treat the condition and complication and no long-term consequences are expected portraying low severity.

In light of our last question, this review points out that implant-related problems occur frequently. It is possible that the positioning of the plate anteriorly can decrease the number of complications. However, only one study mentioned that they felt that plate position initially influenced the outcome and complications of their treatment \[[@CR16]\]. Additionally, plate type and pre-contouring to the anatomic shape of the clavicle may also have an influence. However, the current numbers available are too small and study designs to different to make any assumptions.

Although not optimal with regards to methodological qualities, we included retrospective case series in our analysis. In some studies, the complications were well documented and the reported complication rates were too high to ignore. In particular in the studies by Russo et al. \[[@CR31]\] and Bostman et al. \[[@CR4]\], the authors gave detailed descriptions of encountered complications and the complication rates are high.

There are some limitations to this review. Proceedings from annual meetings (conferences) were not included in this review. Only PUBMED, EMBASE and the Cochrane databases were used for search. Therefore, some valuable information might be lost. However, at proceedings mostly interim analyses are reported and these results might differ from the final results. PUBMED and EMBASE are the largest medical databases. We thoroughly screened the studies and submitted them to a quality assessment which results in an evidence-based conclusion to what extend complications can be attributed to plate fixation. Because of the different study designs and characteristics, data could not be pooled and the data were summarized separately per study. We used the definitions of complications set forth in the analyzed studies to divide the complications into six main categories. However, different authors may have used different definitions for complications i.e. deep, superficial and wound infections. In the future, improvements can be made concerning definitions of complications. Actual complication rates might be higher than many authors report, based on distinctions made between minor and major complications and overlap in definitions (e.g. failure or infection may result in removal, debridement or revision).

Based on the overall low numbers of reported nonunion and symptomatic malunion, we conclude and answer our final question that plate fixation is a safe treatment option for DMCF. However, this review also points out that complications related to the implant material are frequent often requiring removal, revision or debridement of the plate. The quantity of high LoE studies to support this is limited. More prospective trials with well-defined complications as outcome measurements are needed to make more specific recommendations with regard to optimum plate position, the type of plate and possible postoperative complications regarding plate fixation for DMCF.
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Appendix I {#Sec12}
==========

PUBMED/MEDLINE search string {#Sec13}
----------------------------

(((((((((midshaft\[Title/Abstract\]) OR shaft\[Title/Abstract\]) OR shafts\[Title/Abstract\]) OR mid\[Title/Abstract\]) OR midclavicle\[Title/Abstract\]) OR middle\[Title/Abstract\]) OR mid-third\[Title/Abstract\]) OR diaphysis\[Title/Abstract\]) OR diaphyseal\[Title/Abstract\])

AND

(((((((clavicular\[Title/Abstract\]) OR clavicula\[Title/Abstract\]) OR claviculae\[Title/Abstract\]) OR clavicle\[Title/Abstract\]) OR clavicles\[Title/Abstract\]) OR collarbone\[Title/Abstract\]) OR collarbones\[Title/Abstract\])

AND

(((((plating\[Title/Abstract\])OR plate\[Title/Abstract\]) OR plate-osteosynthesis\[Title/Abstract\]) OR plates\[Title/Abstract\]) OR plate-fixation\[Title/Abstract\])

AND

(((fractures\[Title/Abstract\]) OR fracture\[Title/Abstract\]) OR fractured\[Title/Abstract\])

Embase search string {#Sec14}
--------------------

midshaft:ab,ti OR shaft:ab,ti OR shafts:ab,ti OR mid:ab,ti ORmidclavicle:ab,ti OR middle:ab,ti OR third:ab,ti OR diaphysis:ab,ti OR diaphysial;ab,ti AND (clavicular:ab,ti OR clavicula:ab,ti OR claviculae:ab,ti OR clavicle:ab,ti OR clavicles:ab,ti OR collarbone:ab,ti OR collarbones:ab,ti) AND (plating;ab,ti OR plate:ab,ti OR plate-osteosynthesis:ab,ti OR plates:ab,ti OR plate-fixation:ab,ti) AND (fractures:ab,ti OR fracture:ab,ti OR fractured:ab,ti) AND \[embase\]/lim
